Founded in 2001, Truffle Capital is an independent European venture capital firm specializing in life sciences (MedTech and Biotech) and disruptive technologies in the IT sector (FinTech and InsurTech). Truffle Capital's mission is to support the creation and development of innovative young companies capable of becoming tomorrow's leaders. Chaired by Patrick Kron and managed by Dr. Philippe Pouletty and Bernard-Louis Roques, Co-Founders and Managing Directors, Truffle Capital manages €700 million in assets. It has raised more than €1.1 billion since its inception and has supported more than 70 companies in the digital technology and life sciences sectors. In 2019, Truffle Capital has announced the raising of nearly €400 million in new institutional thematic early-stage Funds.
Truffle continue its development further in the value chain with two new thematic late-stage funds (currently in raising) : Truffle MEDEOR(BioMedTech) and Truffle Fintech SCALE-Ups (Fintech/Insurtech), whose first closings should take place in 2022.